Impact BioMedical Inc.
IBO
$0.6437
-$0.0211-3.17%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 130.59% | 53.32% | 34.68% | -6.57% | -17.21% |
| Depreciation & Amortization | 1.07% | 0.18% | -0.09% | 0.18% | 0.18% |
| Other Operating Expenses | 213.93% | 150.00% | 46.61% | 847.06% | 1,009.09% |
| Total Operating Expenses | 15.44% | -8.96% | -15.62% | -6.58% | -3.16% |
| Operating Income | -15.25% | 8.96% | 15.62% | 6.58% | 3.16% |
| Income Before Tax | -790.95% | -449.07% | -461.27% | 113.08% | 47.27% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -791.71% | -449.79% | -462.02% | 116.86% | 42.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -33.33% | -61.46% | -75.40% | -72.61% | -74.47% |
| Net Income | -805.70% | -460.79% | -494.61% | 118.48% | 41.73% |
| EBIT | -15.25% | 8.96% | 15.62% | 6.58% | 3.16% |
| EBITDA | -15.21% | 8.97% | 15.66% | -0.52% | -13.79% |
| EPS Basic | -1,242.26% | -1,180.85% | -2,506.48% | 259.60% | -135.49% |
| Normalized Basic EPS | -339.91% | 116.56% | 147.13% | 360.06% | -366.25% |
| EPS Diluted | -1,292.89% | -1,231.54% | -2,451.64% | -81.58% | -137.24% |
| Normalized Diluted EPS | -468.73% | -69.09% | -237.03% | -197.41% | -366.25% |
| Average Basic Shares Outstanding | -60.61% | -75.03% | -82.15% | -78.37% | -57.45% |
| Average Diluted Shares Outstanding | -10.20% | -41.51% | -57.05% | -56.91% | -57.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |